跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46,120 条关于
“enGene Holdings Inc.”
全部
46,120
临床试验
14,013
药物
2,917
机构
6,304
资讯
22,886
2年前
enGene Appoints Dr. Raj Pruthi as SVP to Advance EG-70 in Urologic Oncology
10个月前
enGene Holdings Reports 63% Complete Response Rate in Phase 2 Bladder Cancer Gene Therapy Trial
去年
enGene's Detalimogene Shows Promise in BCG-Unresponsive Bladder Cancer
9个月前
enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Accelerate Bladder Cancer Gene Therapy Development
去年
Relmada Therapeutics Strengthens NDV-01 Bladder Cancer Program with Key Leadership Appointments Ahead of Phase 3 Trial
8个月前
enGene Secures $125 Million Debt Facility to Advance Bladder Cancer Gene Therapy Toward FDA Approval
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
去年
CERO Therapeutics' CER-1236 Receives FDA Clearance for Clinical Trials
去年
Ignite Proteomics' RPPA Assay Drives Complete Response in HER2-Negative Breast Cancer
去年
Matinas BioPharma's MAT2203 Shows Promise in Combating Severe Fungal Infections
第 1 页,共 2289 页
上一页
下一页